Pinnacle West Asset Management’s AbbVie ABBV Stock Holding History

Pinnacle West Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$435K	–	105
2026 Q1	$435K	Hold	2,000	–	–	0.3%	80
2025 Q4	$457K	Hold	2,000	–	–	0.3%	81
2025 Q3	$463K	Hold	2,000	–	–	0.3%	81
2025 Q2	$371K	Hold	2,000	–	–	0.26%	83
2025 Q1	$419K	Hold	2,000	–	–	0.3%	82
2024 Q4	$355K	Hold	2,000	–	–	0.25%	86
2024 Q3	$395K	Hold	2,000	–	–	0.28%	82
2024 Q2	$343K	Hold	2,000	–	–	0.27%	82
2024 Q1	$364K	Hold	2,000	–	–	0.29%	83
2023 Q4	$310K	Hold	2,000	–	–	0.27%	88
2023 Q3	$298K	Hold	2,000	–	–	0.29%	85
2023 Q2	$269K	Hold	2,000	–	–	0.26%	90
2023 Q1	$319K	Buy	+2,000	New	+$306K	0.33%	83

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pinnacle West Asset Management's ABBV Position: Q2 2026 in Review

Pinnacle West Asset Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 2,000 shares — an estimated $435K sold.

Pinnacle West Asset Management first reported a position in ABBV in Q1 2023 and held it in 13 quarters. The position peaked at $463K in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pinnacle West Asset Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Pinnacle West Asset Management sold 2,000 AbbVie shares in Q2 2026, an estimated $435K.
Pinnacle West Asset Management first reported a position in AbbVie in Q1 2023 and held it in 13 quarters.
Pinnacle West Asset Management's AbbVie position peaked at $463K in Q3 2025.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pinnacle West Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.